U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: October 16-22, 2022
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: October 16-22, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 10/16/2022
Location: Washington, DC
Subject: National Academy of Medicine 50th Anniversary Celebration
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members of the National Academy of Medicine, academia, industry, government, and other invited guests

Event Date: 10/17/2022
Location: Virtual
Subject: The Organization for Professionals in Regulatory Affairs (TOPRA) 2022 Human Medicines Symposium: Lessons Learned and Strategic Priorities
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, media, and other invited attendees

Event Date: 10/17/2022
Location: Washington, DC
Subject: National Organization for Rare Disorders, Rare Diseases, and Orphan Products Breakthrough Summit
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Event Date: 10/17/2022
Location: Virtual
Subject: Great Plains IDeA-CTR Annual Scientific Meeting: Biomedical Research & Healthcare Informatics Conference
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, government, media, and other invited attendees

Event Date: 10/18/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: TRISTAN COLONIUS;
Non FDA Participant/Group: Robert Ford (Abbott Laboratories);

Event Date: 10/19/2022
Location: Virtual
Subject: Foundation for the National Institutes of Health Awards Ceremony
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members of the Foundation for the National Institutes of Health, industry, academia, government, and other invited attendees

Event Date: 10/19/2022
Location: Virtual
Subject: Continued Transformation of the Health Research Enterprise
FDA Participant/Group: N/A
Non FDA Participant/Group: Lisa Simpson (AcademyHealth); Lucas Tramontozzi (SCI Solution);

Event Date: 10/19/2022
Location: Virtual
Subject: 12th Annual Conference of Global Summit on Regulatory Science
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, academia, industry, and other registered attendees

Event Date: 10/20/2022
Location: Virtual
Subject: Reagan Udall Foundation COVID-19 Evidence Accelerator Public Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, academia, industry, media, and other registered attendees

Event Date: 10/20/2022
Location: Virtual
Subject: Foundation for the National Institutes of Health (FNIH) Board of Directors Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members of the FNIH Board of Directors and staff

Event Date: 10/20/2022
Location: Virtual
Subject: Biosimilars Forum Board of Directors Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several board members of the Biosimilars Forum

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 10/17/2022
Location: Virtual
Subject: Foods Program Funding Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Jennifer McEntire (Fresh Produce Association); Donna Garren (American Frozen Food Institute); Mitzi Baum (Stop Foodborne Illness); Brian Ronholm (Consumer Reports); Scott Faber (Environmental Working Group (EWG)); De Ann Davis (Western Growers); Roberta Wagner (Consumer Brands Association);

Event Date: 10/17/2022
Location: Virtual
Subject: Milken Institute FasterCures Virtual Roundtable - Community-Based Infrastructure for Inclusive Research; Speaker: Opening Remarks
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, regulatory organizations, and other stakeholders

Event Date: 10/18/2022
Location: Virtual
Subject: People for the Ethical Treatment of Animals (PETA) Science Consortium International (SCI) Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: April Naab, Jeffrey Brown (People for the Ethical Treatment of Animals (PETA));

Event Date: 10/19/2022
Location: Virtual
Subject: Tobacco Expert Panel Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Charlene Frizzera (CF Health Advisors); Jane Axelrad, Lauren Silvis, Susan Winckler (Reagan-Udall Foundation);

Event Date: 10/19/2022
Location: Virtual
Subject: Cannabis Product Regulation
FDA Participant/Group: N/A
Non FDA Participant/Group: Brian Miller (Miller Research Group);

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 10/17/2022
Location: Geneva, Switzerland
Subject: Substandard and Falsified Medical Products Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Paul Huleatt (World Health Organization Substandard and Falsified Medical Products Steering Committee);

Event Date: 10/17/2022
Location: Geneva, Switzerland
Subject: World Health Organization Substandard and Falsified Medical Products Projects Update
FDA Participant/Group: LEIGH VERBOIS, RUSSELL CAMPBELL
Non FDA Participant/Group: Rutendo Kuwana (World Health Organization);

Event Date: 10/17/2022
Location: Geneva, Switzerland
Subject: Substandard and Falsified Medical Products Meeting
FDA Participant/Group: LEIGH VERBOIS, RUSSELL CAMPBELL
Non FDA Participant/Group: Rogerio Gaspar (World Health Organization);

Event Date: 10/19/2022
Location: Virtual
Subject: European Medicines Agency (EMA) - FDA Collaboration with African Medicines Agency Meeting
FDA Participant/Group: RAVI BHARWANI, ANNA FERUS, DOUGLAS SHAFFER, SEMA HASHEMI, DANIJELA STOJANOVIC
Non FDA Participant/Group: Martin Harvey (European Medicines Agency);

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 10/18/2022
Location: Washington, DC
Subject: National Organization for Rare Disorders, Rare Diseases, and Orphan Products Breakthrough Summit; Panelist: Fireside Chat Session with FDA Center Directors
FDA Participant/Group: PETER MARKS; JEFFREY SHUREN;
Non FDA Participant/Group: Industry, patient advocacy organizations, academia, and other stakeholders

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 10/19/2022
Location: Silver Spring, MD
Subject: American Society of Gene and Cell Therapy and Alliance for Regenerative Medicine Public Meeting; Potency Assays for Cell and Gene Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, and academia stakeholders

Event Date: 10/21/2022
Location: Washington, DC
Subject: ID (Infectious Disease) Week; Moderator: COVID-19 Late Breaking Abstracts
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, and academia stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 10/19/2022
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from the National Association of Tobacco Outlets (NATO)

Event Date: 10/20/2022
Location: Washington, DC
Subject: Food and Drug Law Institute’s (FDLI) Tobacco and Nicotine Products Regulation and Policy Conference; Keynote Address: Programmatic Updates
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, and other stakeholders

Event Date: 10/21/2022
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Representative Raja Krishnamoorthi (D-IL)

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 10/17/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: TRACEY FORFA; PATRICK MCDERMOTT; ANTONIA MONIQUE SENNETT; CHARLOTTE CONWAY; TIMOTHY SCHELL; JEANETTE MURPHY; SIOBHAN DELANCEY; ANNE NORRIS; JENNIFER ERICKSON; DAVID EDWARDS; WILLIAM FLYNN;
Non FDA Participant/Group: Representatives of the Pet Food Institute (PFI)

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top